Co-located cell types help drive aggressive brain tumors, study finds
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...
Weakness in lung cancer's defenses found—an enzyme that boosts cancer cell metabolism
Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, ...
Healio20h
Over a quarter of stem cell transplant survivors develop cutaneous malignant neoplasms
More than one-quarter of blood or marrow transplant survivors developed cutaneous malignant neoplasms, according to study results.Researchers identified several risk factors, including older age, ...
Hosted on MSN3d
MAIA’s lung cancer therapy 99% more likely to improve OS over chemo alone
A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC ...
The Lancet4d
Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study
Estimated geographical and temporal distribution of lung-cancer incidence varied across the four main subtypes worldwide. Our ...
CHMP recommends subcutaneous RYBREVANT® (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
Data from the Phase 3 PALOMA-3 study showed non-inferiority to intravenous administration meeting both co-primary pharmacokinetic (PK) endpoints, as well as a five-fold reduction in infusion-related ...